For millions of people, losing muscle isn't just about weakness; it's about losing independence. Whether caused by Duchenne muscular dystrophy, aging or other degenerative conditions, muscle loss can ...
Patients with Fuchs endothelial corneal dystrophy with particular genetic markers are at higher risk for surgery and vision loss.
An 8-year-old northern Minnesota boy is one of the first in the country to receive a specific type of gene therapy treatment.
Napa in Newport, the annual charity event that supports Newport Beach-based CureDuchenne, returned to The Pendr Beach on ...
Announced the U.S. FDA has accepted our Biologics License Application (BLA) seeking full approval of deramiocel for the treatment of Duchenne muscular dystrophy (DMD) cardiomyopathyBLA granted priorit ...
UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...
9d
GB News on MSNFrom bedwetting to writer's cramp, the success rate of EVERY benefit claim EXPOSED as Labour wields axeFrom wetting the bed to acne, we have crunched the numbers on the success rate of every single disability claim. It comes ...
REGENXBIO (NASDAQ:RGNX – Free Report) had its price target cut by HC Wainwright from $36.00 to $34.00 in a research report ...
Preservation of Skeletal Muscle Function Shown Over 3 Years Resulting in 52% Slowing of Disease-- --Data Presented at the 2025 Muscular Dystrophy Association (MDA) Conference-- SAN DIEGO, March ...
Scholar Rock will present new Phase 3 SAPPHIRE trial data on apitegromab at the 2025 MDA conference, highlighting efficacy ...
YOU'VE PROBABLY HEARD big guys at the gym tossing around the word "hypertrophy" when they talk about their lifting goals — but what does that even mean? Are the principles behind the term just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results